| Empagliflozin group (N = 20) | Control group (N = 15) | ||||
---|---|---|---|---|---|---|
Baseline | 1-month | 3-month | Baseline | 1-month | 3-month | |
Plasma viscosity | 1.48 ± 0.09 | 1.49 ± 0.11 | 1.52 ± 0.10 | 1.47 ± 0.10 | 1.41 ± 0.06 | 1.46 ± 0.03 |
Blood viscosity (45/s) | 6.80 ± 0.98 | 7.47 ± 1.79^ | 7.53 ± 1.05*^ | 6.59 ± 0.88 | 6.41 ± 0.69 | 6.35 ± 0.82 |
Blood viscosity (90/s) | 5.77 ± 0.72 | 6.11 ± 1.10^ | 6.29 ± 0.81*^ | 5.51 ± 0.69 | 5.35 ± 0.57 | 5.35 ± 0.64 |
Blood viscosity (225/s) | 4.87 ± 0.57 | 5.19 ± 0.75^ | 5.32 ± 0.66*^ | 4.66 ± 0.56 | 4.53 ± 0.50 | 4.98 ± 0.73 |
Hematocrit (%) | 46.5 ± 3.7 | 48.2 ± 3.8^ | 49.4 ± 3.8#^ | 45.0 ± 4.3 | 44.0 ± 4.5 | 43.9 ± 4.5 |